BLAZE Receives SOC 1 Certification
Cannabis software company BLAZE Solutions, Inc. validated its data performance and implementation and gained SOC 1 Certification.
Cannabis Global Provides Patent Applications Update – For Its Cannabis Nanoparticles And Insect Produced Cannabosides
Cannabis Global, Inc. (OTCPK:CBGL) provided an update concerning the company's patent applications, especially relating to its application to protect inventions and processes for cannabis nanoparticles.
iAnthus Reports Losses, Q2 Revenue Drops 20% YoY
iAnthus Capital Holdings, Inc. (OTCPK:ITHUF) (CSE:IAN) Q2 2022 revenue was $43.5 million, a sequential increase of 2% from Q1 2022 and a decrease of 20% from the same period in the prior year.
Q2 2022 Financial Highlights
Despite Lower Equipment Demand In The Cannabis Market urban-gro Q2 Revenue Grows Thanks To This
urban-gro, Inc. (NASDAQ: UGRO) released second quarter financial results, revealing revenue was $16.3 million, an increase of 27%, compared to $12.8 million in the prior year period.
Greenlane Q2 Revenue Grows 15% YoY, Provides Outlook
Greenlane Holdings, Inc. (NASDAQ: GNLN) Q2 2022 revenue increased 15% to $39.9 million, compared to $34.7 million in Q2 2021.
Financial Results
TILT Q2 Revenue Slightly Slides YoY, Saved By Growing Cannabis Operations
TILT Holdings Inc. (OTCQX: TLLTF) (NEO:TILT) Q2 2022 revenue was $47.1 million, a 2.88% decrease compared to $48.5 million in the prior year.
IM Cannabis Q2 Revenue Grows 114% YoY, What About Profit?
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million).
Q2 2022 Financial Results
Columbia Care Q2 Revenue Grows 18.1% YoY, What About Adjusted EBITDA?
Columbia Care Inc. (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) (FSE: 3LP) released financial results for the second quarter ended June 30, 2022, revealing revenue of $129.6 million, an 18.1% increase compared to $109.7 million in Q2 2021.
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.
Agrify Q2 Revenue Grows 63.5% YoY, What About Net Loss?
Agrify Corporation (NASDAQ: AGFY) released financial results for the second quarter ended June 30, 2022, revealing revenue of $19.3 million, an increase of 63.5% compared to $11.8 million for the prior year